Dr Reddys Laboratories

1,206.20

-26.80

(-2.17%)

Market Cap

1,00,679.14 Cr

PE Ratio

32.41

Volume

26,07,818.00

Day High - Low

1,233.90 - 1,194.90

52W High-Low

1,414.90 - 1,101.00

compare with

Sun Pharmaceutical

1,801.00 (-0.86%)

Divis Laboratories

9,249.00 (-0.46%)

Torrent Pharmaceuticals

4,767.30 (-0.68%)

Zydus Life Science

1,145.70 (-1.40%)

Cipla

1,344.00 (-0.15%)

Key Fundamentals

Market Cap

1,00,679.14 Cr

EPS

50.41

PE Ratio

32.41

PB Ratio

2.71

Book Value

456.14

EBITDA

7,811.90

Dividend Yield

0.65 %

Industry

Healthcare

Sector

Pharmaceuticals

Return on Equity

10.87

Debt to Equity

0.17

Actual

Company News

View All News

Dr Reddy's subsidiary faces $32,350 IRS penalty

20 hrs ago

Dr Reddy's Laboratories' US subsidiary DRL Inc received a $32,350.20 IRS penalty for tax misclassification. The company states there is no material impact on its financials or operations.

Dr Reddys to host Nomura group meet in Hyderabad

Sep 21, 2026

Dr Reddys Laboratories Ltd will hold an in-person group meeting with Nomura on September 25, 2026, in Hyderabad. The session is scheduled from 11:00 am to 2:00 pm as per SEBI disclosure norms.

Dr. Reddy's signs exclusive deal with Takeda for Qdenga vaccine in India

Sep 18, 2026

Dr. Reddy's Laboratories has entered an exclusive distribution agreement with Takeda for Qdenga, India's first approved dengue vaccine. The partnership targets the private market, with availability expected in H1 2027.

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,801.00	#1 4,32,120.23	36.04	#1 61,673.90	12.69	#1 11,565	26.53	36.68
Divis Laboratories	9,249.00	2,45,531.89	84.24	11,067.00	13.95	2,568	65.50	51.70
Torrent Pharmaceuticals	4,767.30	1,81,332.77	84.71	13,886.20	20.34	2,138	3.28	41.12
Zydus Life Science	1,145.70	1,14,284.01	25.27	27,657.90	17.64	5,026	-34.90	47.64
Cipla	1,344.00	1,08,576.18	32.50	29,044.60	2.24	3,870	-39.18	34.78
Laurus Labs	1,984.00	1,07,197.94	98.20	6,867.80	22.01	890	#1 123.93	58.70
Mankind Pharma	2,535.00	1,04,706.93	50.04	14,636.40	14.85	1,938	29.13	61.75
Dr Reddys Laboratories	1,206.20	#8 1,00,679.14	#4 32.41	#2 35,058.60	#9 3.90	#4 4,158	#10 -69.10	53.84
Aurobindo Pharma	1,676.80	96,479.37	25.84	34,145.20	5.56	3,503	25.21	50.30
Lupin	2,031.20	92,884.74	#1 16.82	29,038.90	#1 26.75	5,356	16.00	31.59

Automatic Screeners on ScanX

10% near 52 Week Low

Support 1 Breached

Support 2 Breached

Growth Rate

Revenue Growth

3.90 %

Net Income Growth

-27.38 %

Cash Flow Change

22.20 %

ROE

-35.57 %

ROCE

-36.29 %

EBITDA Margin (Avg.)

-22.04 %

Corporate Action

Record Date	Corporate Action	Information	Announcement Day	LTP at Annoucement	LTP at Record Day
23 Oct 2026	Quarterly Result Announcement	NA	23 Oct 2026	1,202.00	1,200.10
13 Jul 2021	Dividend	₹ 25.00 /share	09 Jul 2021	1,060.40	1,097.91
13 Jul 2022	Dividend	₹ 30.00 /share	11 Jul 2022	781.62	896.74
12 Jul 2023	Dividend	₹ 40.00 /share	11 Jul 2023	986.65	1,033.17
17 Jul 2024	Dividend	₹ 40.00 /share	16 Jul 2024	1,258.69	1,329.21
29 Jul 2024	Annual General Meeting	NA	29 Jul 2024	1,258.69	1,378.43
28 Oct 2024	Split	1:5	28 Oct 2024	1,378.43	1,302.94
05 Nov 2024	Quarterly Result Announcement	NA	05 Nov 2024	1,310.23	1,268.30
23 Jan 2025	Quarterly Result Announcement	NA	23 Jan 2025	1,343.65	1,296.25
09 May 2025	Quarterly Result Announcement	NA	09 May 2025	1,187.20	1,148.00
10 Jul 2025	Dividend	₹ 8.00 /share	10 Jul 2025	1,148.00	1,269.40
23 Jul 2025	Quarterly Result Announcement	NA	23 Jul 2025	1,325.45	1,240.40
24 Jul 2025	Annual General Meeting	NA	24 Jul 2025	1,148.00	1,247.40
24 Oct 2025	Quarterly Result Announcement	NA	24 Oct 2025	1,321.70	1,279.40
21 Jan 2026	Quarterly Result Announcement	NA	21 Jan 2026	1,283.85	1,166.70
12 May 2026	Quarterly Result Announcement	NA	12 May 2026	1,298.90	1,279.70
10 Jul 2026	Dividend	₹ 8.00 /share	10 Jul 2026	1,279.70	1,269.50
22 Jul 2026	Quarterly Result Announcement	NA	22 Jul 2026	1,271.55	1,206.00
23 Jul 2026	Annual General Meeting	NA	23 Jul 2026	1,279.70	1,183.00

Funding House	Current Holding %	1M Change	1M Change %	3M Change %
The Wealth Company Mid Cap Fund Direct-Growth	3.72%	55000	3.72%	3.72%
SBI Nifty100 Low Volatility 30 Index Fund Direct-Growth	0.00%	-13407	-2.58%	-3.19%
Groww Multi Asset Allocation Fund Direct-Growth	0.40%	13395	0.40%	-0.73%
The Wealth Company Multi Asset Allocation Fund Direct-Growth	0.00%	-5000	-0.30%	0.00%
AlphaGrep Multi Asset Allocation Fund Direct-Growth	0.65%	3901	0.58%	0.65%
UTI Nifty 500 Index Fund Direct-Growth	0.35%	3353	0.35%	0.35%
AlphaGrep Flexi Cap Fund Direct-Growth	0.67%	2920	0.67%	0.67%
Parag Parikh Large Cap Fund Direct-Growth	0.52%	1800	0.01%	-0.09%
Axis Nifty50 Equal Weight Index Fund Direct-Growth	1.71%	-899	0.02%	1.71%
DSP Nifty Healthcare Index Fund Direct-Growth	6.05%	712	-0.03%	-1.56%
JioBlackRock Sector Rotation Fund Direct-Growth	0.57%	483	0.02%	-0.14%
Nippon India BSE Sensex Next 30 Index Fund Direct-Growth	2.65%	430	0.04%	-0.54%
UTI Nifty500 Shariah Index Fund Direct-Growth	1.15%	-311	-0.04%	-0.34%
Zerodha Nifty 50 Index Fund Direct-Growth	0.64%	200	0.02%	-0.11%
Nippon India Nifty India Manufacturing Index Fund Direct-Growth	1.63%	198	-0.01%	-0.36%
JioBlackRock Nifty 50 Index Fund Direct-Growth	0.64%	-169	0.01%	-0.12%
Groww Nifty 50 Index Fund Direct-Growth	0.64%	82	0.01%	-0.12%
Zerodha Life Cycle Fund 2041 Direct-Growth	0.20%	75	0.01%	0.20%
Zerodha Life Cycle Fund 2036 Direct-Growth	0.16%	65	0.00%	0.16%
Edelweiss Nifty LargeMidcap250 Plus 8-13 Yr G-Sec 70:30 Index Fund Direct-Growth	0.18%	34	0.00%	-0.03%
DSP Nifty 500 Index Fund Direct-Growth	0.35%	24	0.00%	-0.07%
Zerodha Nifty LargeMidcap250 Plus 8-13 Yr G-Sec 70:30 Index Fund Direct-Growth	0.18%	15	0.00%	-0.02%
Nippon India Nifty 500 Low Volatility 50 Index Fund Direct-Growth	2.02%	8	0.15%	-0.42%
Choice Nifty 50 Index Fund Direct-Growth	0.64%	6	0.02%	-0.11%
Bajaj Finserv Nifty 50 Index Fund Direct-Growth	0.64%	-4	0.01%	-0.11%

Technical Indicators

RSI(14)

Neutral

53.84

ATR(14)

Volatile

25.56

STOCH(9,6)

Neutral

74.33

STOCH RSI(14)

Neutral

74.82

MACD(12,26)

Bullish

6.46

ADX(14)

Strong Trend

29.16

UO(9)

Bearish

51.95

ROC(12)

Uptrend And Accelerating

5.34

WillR(14)

Neutral

-37.95

About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

Part of Raise Financial Services

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357 Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104

Dr Reddys Laboratories

Company News

Peer Comparison Compare Peers on Screener

Automatic Screeners on ScanX

Corporate Action

Mutual Fund Holdings

Technical Indicators